Comparison of the Swedish and Finnish Centers in the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Background and objective: The European Randomized Study of Screening for Prostate Cancer showed 20% reduction in prostate cancer (PC) mortality after 16 year follow-up of prostate-specific antigen (PSA) based screening, but effects varied: 9% in Finland (FinRSPC) vs 37% in Sweden (Göteborg-1) in scr...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Marianne Månsson, Kirsi Talala, Anssi Auvinen, Jonas Hugosson
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2026-06-01
Reeks:	European Urology Open Science
Onderwerpen:	Cancer-specific mortality Contamination Prostate cancer Prostate-specific antigen Screening
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2666168326004933
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!